yes i take peptides · shopping companion

Vesugen

Category · For LongStatus · RUOCitations · 27Russian-only data

The verdict

A three-amino-acid peptide from the Khavinson 'short peptide bioregulator' family. Pitched for vascular health. Same evidence pattern as Epitalon — one lab, mostly Russian-language.

By source — cost, legality, risk

Brand
Not available
None — no FDA approval; no Western development
No FDA-approved vesugen exists.
Compounded 503A pharmacy
$100–$220/mo where sold
Off-label · niche channel, not on bulks list
Mid–high. Few compounders carry; the Khavinson-only evidence base means clinical legitimacy is weak.
RUO research peptide
$30–$120/mo
Sold 'for research only'
Highest. The dominant supply; small tripeptide is cheap to synthesize.
Gray-market raw
Varies — not on user's vendor list
Unregulated overseas import
Available via overseas raws (cheap to synthesize) but vesugen has limited demand vs Epitalon, so supply is intermittent.

Sources · top 5 of 27

01Meshchaninov VN, et al. [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]. Advances in gerontology = Uspekhi gerontologii. 2015;28(1):62-7. PMID: 26390612.
02Khavinson VKh, et al. Peptides tissue-specifically stimulate cell differentiation during their aging. Bulletin of experimental biology and medicine. 2012;153(1):148-51. PMID: 22808515.
03Khavinson VKh, et al. [Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging]. Advances in gerontology = Uspekhi gerontologii. 2014;27(1):108-14. PMID: 25051766.
04Linkova NS, et al. Peptidegic stimulation of differentiation of pineal immune cells. Bulletin of experimental biology and medicine. 2011;152(1):124-7. PMID: 22803057.
05Kozina LS. [Investigation of antihypoxic properties of short peptides]. Advances in gerontology = Uspekhi gerontologii. 2008;21(1):61-7. PMID: 18546825.